Welcome to our dedicated page for Hudson Executive news (Ticker: HIII), a resource for investors and traders seeking the latest updates and insights on Hudson Executive stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hudson Executive's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hudson Executive's position in the market.
Hudson Executive Investment Corp. III (Nasdaq: HIII) will dissolve and liquidate as it has failed to complete a business combination within the required timeframe. Shareholders can expect a redemption price of approximately $10.10 per share on December 21, 2022. The company has instructed its trustee to liquidate its trust account for distribution to shareholders. Additionally, HIII plans to delist its securities from NASDAQ and terminate its registration under the Securities Exchange Act of 1934.
FAQ
What is the market cap of Hudson Executive (HIII)?
